BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Day A, Wood J, Melton S, Bryant RV. Exclusive enteral nutrition: An optimal care pathway for use in adult patients with active Crohn's disease. JGH Open 2020;4:260-6. [PMID: 32280775 DOI: 10.1002/jgh3.12256] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Gulliver EL, Young RB, Chonwerawong M, D'Adamo GL, Thomason T, Widdop JT, Rutten EL, Rossetto Marcelino V, Bryant RV, Costello SP, O'Brien CL, Hold GL, Giles EM, Forster SC. Review article: the future of microbiome-based therapeutics. Aliment Pharmacol Ther 2022;56:192-208. [PMID: 35611465 DOI: 10.1111/apt.17049] [Reference Citation Analysis]
2 Melton SL, Fitzpatrick JA, Taylor KM, Halmos EP, Gibson PR. Lessons from an audit of exclusive enteral nutrition in adult inpatients and outpatients with active Crohn’s disease: a single-centre experience. Frontline Gastroenterol. [DOI: 10.1136/flgastro-2022-102173] [Reference Citation Analysis]
3 Gu P, Feagins LA. Diet in the Pathogenesis and Management of Crohn's Disease. Gastroenterol Clin North Am 2022;51:319-35. [PMID: 35595417 DOI: 10.1016/j.gtc.2021.12.008] [Reference Citation Analysis]
4 Fitzpatrick JA, Melton SL, Yao CK, Gibson PR, Halmos EP. Dietary management of adults with IBD - the emerging role of dietary therapy. Nat Rev Gastroenterol Hepatol 2022. [PMID: 35577903 DOI: 10.1038/s41575-022-00619-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
5 Burgess D, McGrath KH, Watson C, Collins T, Brown S, Marks K, Dehlsen K, Herbison K, Landorf E, Benn L, Fox J, Liew M. Exclusive enteral nutrition: An optimal care pathway for use in children with active luminal Crohn's disease. J Paediatr Child Health 2022. [PMID: 35181966 DOI: 10.1111/jpc.15911] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
6 Hart L, Verburgt CM, Wine E, Zachos M, Poppen A, Chavannes M, Van Limbergen J, Pai N. Nutritional Therapies and Their Influence on the Intestinal Microbiome in Pediatric Inflammatory Bowel Disease. Nutrients 2021;14:4. [PMID: 35010879 DOI: 10.3390/nu14010004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
7 Shariff S, Moran G, Grimes C, Cooney RM. Current Use of EEN in Pre-Operative Optimisation in Crohn's Disease. Nutrients 2021;13:4389. [PMID: 34959941 DOI: 10.3390/nu13124389] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Mitrev N, Huang H, Hannah B, Kariyawasam VC. Review of exclusive enteral therapy in adult Crohn's disease. BMJ Open Gastroenterol 2021;8:e000745. [PMID: 34580154 DOI: 10.1136/bmjgast-2021-000745] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
9 Chiu E, Oleynick C, Raman M, Bielawska B. Optimizing Inpatient Nutrition Care of Adult Patients with Inflammatory Bowel Disease in the 21st Century. Nutrients 2021;13:1581. [PMID: 34065070 DOI: 10.3390/nu13051581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Tao F, Xing X, Wu J, Jiang R. Enteral nutrition modulation with n-3 PUFAs directs microbiome and lipid metabolism in mice. PLoS One 2021;16:e0248482. [PMID: 33764993 DOI: 10.1371/journal.pone.0248482] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Day AS, Wood JA, Halmos EP, Bryant RV. Practical Guidance for Dietary Management of Patients With Inflammatory Bowel Disease During the SARS-CoV2 Pandemic. J Acad Nutr Diet 2021;121:201-9. [PMID: 32855101 DOI: 10.1016/j.jand.2020.07.019] [Reference Citation Analysis]